| CAS No. | 705260-08-8 |
|---|---|
| MDL No. | MFCD16038877 |
| MF | C29H35FN2O8S |
| MW | 590.70 |
| InChI Key | NQRYCIGCIAWEIC-CKLVGUEFSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 5 mg | 97% | $107 | In Stock | |
| 10 mg | 97% | $150 | In Stock | |
| 25 mg | 97% | $275 | In Stock | |
| 50 mg | 97% | $391 | In Stock | |
| 100 mg | 97% | $663 | In Stock | |
| 250 mg | 97% | $1189 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Vorapaxar sulfate is an organic sulfate salt formed by combining vorapaxar with one molar equivalent of sulfuric acid. It is a protease-activated receptor-1 antagonist used to reduce thrombotic cardiovascular events in patients with a history of myocardial infarction or peripheral arterial disease. It reduces the rate of a combined endpoint including cardiovascular death, MI, stroke, and urgent coronary revascularization. It functions as a cardiovascular drug, platelet aggregation inhibitor, and protease-activated receptor-1 antagonist. It contains vorapaxar(1+).
| CAS No. | 705260-08-8 |
|---|---|
| Product Name | Vorapaxar Sulfate |